Tamas Pinter
Overview
Explore the profile of Tamas Pinter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
4489
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Csaba M, Megyesfalvi Z, Bathory-Fulop L, Pinter T, Agocs L, Dome B, et al.
Front Oncol
. 2025 Jan;
14():1462865.
PMID: 39777340
Gestational trophoblastic neoplasms are tumors that occur during pregnancy, while non-gestational trophoblastic tumors have a similar histology but are present outside of gestation. Literature reports several cases of non-gestational trophoblastic...
2.
Toth E, Kuronya Z, Soos E, Pinter T, Butz H, Horvath Z, et al.
Acta Oncol
. 2024 Jun;
63:433-440.
PMID: 38881341
Aim: The study aims to evaluate the clinical benefit of CGP in our Comprehensive Cancer Center Methods and patients: CGP was introduced into our routine clinical practice in 2021. An...
3.
Lerant G, Torok B, Toth E, Pinter T, Godeny M
Laryngoscope
. 2024 Jun;
134(11):4577-4581.
PMID: 38847090
Ewing sarcoma of the larynx is extremely rare, only a few number of cases have been reported. In this report, we describe a case of extraskeletal Ewing sarcoma of the...
4.
Freyer G, Martinez-Janez N, Kukielka-Budny B, Ulanska M, Bourgeois H, Munoz M, et al.
Breast
. 2024 Feb;
74:103681.
PMID: 38377732
Introduction: Single-agent oral vinorelbine is a standard of care for hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (ABC) that has progressed on endocrine therapy. Metronomic...
5.
Vesztergom D, Szekely B, Hegyi B, Masszi A, Pinter T, Csako B, et al.
Orv Hetil
. 2023 Jul;
164(29):1134-1145.
PMID: 37481767
In Hungary, an average of 2066 women under the age of 40 are diagnosed with cancer each year according to data from the National Cancer Registry. Approximately two-thirds of these...
6.
Landherr L, Pinter T, Hornyak L, Revesz J, Mahr K, Torday L, et al.
Magy Onkol
. 2022 Mar;
66(1):11-19.
PMID: 35343970
The primary aim of AVACONT was to collect data in the course of routine oncological care from patients with metastatic colorectal cancer (mCRC) treated with bevacizumab supplemented fluoropyrimidine-based chemotherapy doublet...
7.
Freihat O, Zoltan T, Pinter T, Kedves A, Sipos D, Repa I, et al.
Cancers (Basel)
. 2022 Feb;
14(3).
PMID: 35159115
Background: This study aimed to assess the association of 18F-Fluorodeoxyglucose positron-emission-tomography (18F-FDG/PET) and DWI imaging parameters from a primary tumor and their correlations with clinicopathological factors. Methods: We retrospectively analyzed...
8.
Freihat O, Toth Z, Pinter T, Kedves A, Sipos D, Cselik Z, et al.
Oral Oncol
. 2021 Feb;
116:105239.
PMID: 33640578
Objectives: To determine the feasibility of pre-treatment primary tumor FDG-PET and DWI-MR imaging parameters in predicting HPV status and the second aim was to assess the feasibility of those imaging...
9.
Freihat O, Pinter T, Kedves A, Sipos D, Cselik Z, Repa I, et al.
Cancer Imaging
. 2020 Aug;
20(1):56.
PMID: 32771060
Background: To determine the usefulness of Diffusion Weighted Imaging (DWI) derived from PET/MRI in discriminating normal from metastatic lymph nodes and the correlation between the metastatic lymph nodes with the...
10.
Finn R, Boer K, Bondarenko I, Patel R, Pinter T, Schmidt M, et al.
Breast Cancer Res Treat
. 2020 Jul;
183(2):419-428.
PMID: 32683565
Purpose: Palbociclib is a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, approved in combination with endocrine therapy for the treatment of women and men with hormone receptor-positive, human epidermal growth factor receptor...